|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital and Faculty of Health Sciences, DK-8000 Aarhus C, Denmark
2 Department of Surgery, University of Tennessee Health Science Center, Memphis TN 38163, Tennessee, USA
3 Department of Gynecology and Obstetrics, Skejby Sygehus, Aarhus University Hospital, DK-8200 Aarhus N, Denmark
4 Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis TN 38163, Tennessee, USA
* To whom correspondence should be addressed. E-mail: Jens.Bruun{at}iekf.au.dk.
Interleukin-8 (IL-8) is released from the human adipose tissue. Circulating IL-8 is increased in obese as compared to lean subjects and associated with measures of insulin resistance, development of atherosclerosis and cardiovascular disease. We studied the production and release of IL-8 in vitro from 1) paired samples of subcutaneous (SAT) and visceral (VAT) adipose tissue, and 2) the production of IL-8 from whole adipose tissue, isolated adipocytes and non-fat cells of adipose tissue. IL-8 release from VAT was 4-fold higher than from SAT (p < 0.05) and IL-8 mRNA was 2-fold higher in VAT as compared to SAT (p < 0.01). Dexamethasone (50 nM) attenuated IL-8 production by 50 % (p < 0.05) and IL-1
(2 µg/L) increased IL-8 production by up to 15-fold (p < 0.001). IL-8 release from whole SAT explants correlated with BMI (r = 0.78; p < 0.001) as did IL-8 release from non-fat cells (r = 0.79; p < 0.001). However, no correlation was found between IL-8 release from the fraction of isolated adipocytes and BMI (r = 0.01). In conclusion we demonstrated an increased release of IL-8 from VAT as compared to SAT. Furthermore, our data suggest that the observed elevation in circulating levels of IL-8 in obese subjects is due primarily to the release of IL-8 from non-fat cells from adipose tissue. The high levels of IL-8 release from human adipose tissue and accumulation of this tissue in obese subjects may account for some of the increase in circulating IL-8 observed in obesity.
This article has been cited by other articles:
![]() |
V. Elgazar-Carmon, A. Rudich, N. Hadad, and R. Levy Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding J. Lipid Res., September 1, 2008; 49(9): 1894 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Flynn, B. K. McFarlin, and M. M. Markofski State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training American Journal of Lifestyle Medicine, May 1, 2007; 1(3): 220 - 235. [Abstract] [PDF] |
||||
![]() |
G. Fantuzzi and T. Mazzone Adipose Tissue and Atherosclerosis: Exploring the Connection Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 996 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-Z. Yang, M.-J. Lee, H. Hu, J. Pray, H.-B. Wu, B. C. Hansen, A. R. Shuldiner, S. K. Fried, J. C. McLenithan, and D.-W. Gong Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1253 - E1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bruun, J. W. Helge, B. Richelsen, and B. Stallknecht Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E961 - E967. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Curat, A. Miranville, C. Sengenes, M. Diehl, C. Tonus, R. Busse, and A. Bouloumie From Blood Monocytes to Adipose Tissue-Resident Macrophages: Induction of Diapedesis by Human Mature Adipocytes Diabetes, May 1, 2004; 53(5): 1285 - 1292. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |